Flavin Mononucleotide: Clinical Trials

4 trials of Flavin Mononucleotide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 unknown, 1 withdrawn. 2 Phase 3, 1 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 32Unknown 1, Withdrawn 1
Not applicable1Not yet recruiting 1
Phase 21Unknown 1
Phase 41Completed 1

Follow Flavin Mononucleotide: new trials by email Literature Review of Flavin Mononucleotide trials Research Report on Flavin Mononucleotide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized Clinical Trial of Ex Vivo Corneal Cross-Linking of Donor Keratoplasty Tissue for Keratoconus Used for Keratoplasty in Keratoconus Patients
Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% with UV light, Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% without UV light - Keratoconus
Not applicableNot yet recruitingJoseph B. Ciolino, MD2162027-01-012026-04-08
Epi-On Corneal Crosslinking for Keratoconus
Riboflavin 5'-Phosphate - Keratoconus, Keratoconus, Unstable
Phase 4CompletedComprehensive EyeCare of Central Ohio202017-07-182020-01-28
The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer
Mesalazine Sustained-Release Tablets, Riboflavin Sodium Phosphate Injection - Crohn's Disease, Oral Ulcer
Phase 3WithdrawnXijing Hospital of Digestive Diseases2016-03-012023-02-01
Treatment of Keratoconus Using Collagen Cross-Linking
Riboflavin-5-phosphate, Sham cross-linking - Keratoconus
Phase 2 / Phase 3UnknownUniversity at Buffalo1502008-09-012009-02-11

Conditions studied

Keratoconus (3)  ·  Corneal Diseases (1)  ·  Crohn Disease (1)  ·  Dilatation, Pathologic (1)  ·  Oral Ulcer (1)

Sponsors

Comprehensive EyeCare of Central Ohio (1)  ·  Joseph B. Ciolino, MD (1)  ·  University at Buffalo (1)  ·  Xijing Hospital of Digestive Diseases (1)

Countries

United States (3)  ·  China (1)

Top investigators

James J Reidy, M.D. (1)  ·  Joseph B Ciolino (1)  ·  Kenneth A Beckman, M.D. (1)  ·  Ying Han, Ph. D (1)

Results publications

PMID 12719068, PMID 16565005, PMID 16765803, PMID 16900027, PMID 16952090, PMID 17457183, PMID 17457184, PMID 17531694, PMID 17720054